Quality Management
Last Updated: 08 July 2026
The IEC 62366 Usability Rules for Medical Devices topic covers the usability engineering and safety requirements addressed through IEC 62366-1:2015 and its 2020 amendment. The medical device market requires a clear understanding of usability engineering and safety rules. Aesthetic appearance and a well-designed user interface do not matter if the manufacturer cannot prove that the engineering process is safe. Safety related to device use is acceptable only when the manufacturer follows the required engineering steps and keeps proper records. During product development, human factors validation testing must demonstrate that the device mitigates use errors in a simulated clinical environment.
IEC 62366 Usability Rules for Medical Devices and Medical Device Risk Management
Navigating the usability side of medical devices requires understanding how the process affects safety. A documented medical device risk management process must track correct use alongside user mistakes or use errors during normal use. The standard can identify abnormal use, such as reckless operation or intentionally ignoring instructions, but it does not provide tools to assess or mitigate those specific actions. Device usability is considered acceptable when the engineering process is followed fully unless post-market data later shows a problem. The standard does not apply to clinical decision-making by the user.
Global Framework and the International Organization for Standardization
When selling a device in modern target markets, the updated rules change how manufacturers track quality and risk alignment. The connection with the international organization for standardization is reflected in the updated references used throughout the lifecycle. Foundational risk management references that previously pointed to the 2007 standard are replaced by ISO 14971:2019. A medical device risk management process should follow the current lifecycle requirements. Quality management systems also move to ISO 13485:2016, while safety characteristics and user interface work refer to ISO/TR 24971:2020.
Essential Principles Mapping for International Market Entry
For general medical devices, the usability engineering steps map to ISO 16142-1:2016 Annex B, which covers basic safety principles and known user risks. For this testing device, you need to follow the safety and instruction rules in ISO 16142-2:2017 Annex B. These newer standards replace the old 2006 guidelines.
Mandatory Documentation and the Usability Engineering File
Manufacturers must establish and maintain a dedicated usability engineering file, often called the UEF. The records can remain inside the main design history or risk files, but the UEF must contain clear references to all required data. Anyone doing this work must show they have the right training or experience. A standard product realization process in the QMS must explicitly reference this usability loop.
Required Components of the Use Specification
You need to prepare a detailed Use Specification that describes the context in which the device is operated. It must document the intended medical indication, target patient group, and the body parts or tissue types that interact with the device. It also requires a formal User Profile covering the physical and mental characteristics of intended users. The Use Environment must include lighting and noise levels, along with social factors such as team dynamics, high-stress environments, and long shifts. The basic operating principle must also be defined.
Risk Control and Safety Technical Requirements
To reduce use-related risks, the standard requires a strict priority sequence from ISO 14971:2019. Within medical device risk management, the manufacturer must first design out the danger, then apply protective measures in the device or manufacturing process, and finally provide safety information or user training. If warnings are used as a control, they must pass through the usability process to show that users notice and understand them. These rules help shape the User Interface Specification. This document sets clear technical requirements to test against and notes if you need to create training or manuals.
IEC 62366 Usability Rules for Medical Devices Formative and Summative Evaluation
You need a User Interface Evaluation Plan that clearly states your goals and how you plan to test them. If usability tests are conducted, the plan must detail user profiles, the test environment, and whether instructions are provided. When training takes place before testing, the plan should include an elapsed-time delay to allow for natural learning decay. Formative tests are performed iteratively to identify blind spots and user interface weaknesses. These early iterations stop when late-stage formative results provide enough confidence that the final summative evaluation can show that residual risk is acceptable. The final summative evaluation must test high-risk scenarios using a production-ready interface. The plan must justify how subjects represent real users, how groups and sample sizes were selected, what defines correct use, and how errors and difficulties are recorded.
Legacy Interfaces and User Interfaces of Unknown Provenance
For an older legacy interface that lacks standard development records, Annex C provides a retrospective route. If a legacy interface is modified, only the unchanged parts keep User Interface of Unknown Provenance status, while altered components require full standard testing. The retrospective process requires a recreated use specification, review of post-market data for known use errors, confirmation that usability hazards are tracked in the risk analysis, and verification that current controls reduce risks to acceptable levels. The overall residual risk must then be reassessed under ISO 14971:2019 and the relevant guidance from the international organization for standardization. Changes needed to correct a safety issue cannot use the legacy route and must follow the standard development process.
Medical Device Regulatory Consulting Services from Morulaa
Implementing IEC 62366 can be managed internally or supported by external medical device regulatory consulting services. Morulaa HealthTech can assist with:
Protocol development and study design for usability testing
Recruitment of representative users across geographies
Moderation of formative and validation studies
Integration of usability engineering with regulatory strategy
Preparation of usability documentation required for regulatory submissions, including FDA submissions
As a medical device and IVD consultancy, our medical device regulatory consulting services support manufacturers with IEC 62366 implementation, usability studies, and documentation for EU and US regulators. Whether you are starting a new project or updating an existing device, the team helps you prepare compliant documentation and deliver safer devices to market.
Morulaa provides medical device regulatory consulting services for manufacturers seeking practical guidance on IEC 62366 Usability Rules for Medical Devices, usability testing, risk integration, and submission-ready records.
Frequently Asked Questions
What are the target-market registration fees and review costs for submitting the UEF?
The document does not contain information on submission fees, regulatory costs, or review expenses for registering a device or submitting a usability engineering file.
What are the official regulatory review timelines for usability documentation?
The document does not provide timeline information. It does not mention operational schedules, waiting periods, or processing timeframes for regulatory reviews.
Does the target market require clinical data, clinical trials, or specific efficacy endpoints?
The document does not provide information on clinical data or clinical-trial requirements for market access. It notes that the standard does not apply to clinical decision-making and that effectiveness under the standard refers to user accuracy and completeness rather than clinical effectiveness.
Will target-market auditors conduct an onsite visit or physical audit of an overseas manufacturing facility?
The document does not provide information on facility audits, onsite inspections, or site visits by country-specific auditors. It only notes that compliance with the usability standard is verified through a document review of the UEF.
What commercial barriers or administrative trade restrictions are enforced by the target market?
The document does not contain information on commercial barriers to entry, tariffs, import controls, or market-registration restrictions.